Denali Therapeutics, Inc. (DNLI)
19.58
-0.48
(-2.39%)
USD |
NASDAQ |
Mar 19, 13:33
Denali Therapeutics Total Assets (Quarterly) : 1.145B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 82.35M |
| Enovis Corp. | 3.835B |
| Twist Bioscience Corp. | 638.08M |
| Agenus, Inc. | 226.80M |
| Curis, Inc. | 27.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 131.09M |
| Shareholders Equity (Quarterly) | 1.014B |
| Debt to Equity Ratio | 0.0417 |
| Current Ratio | 9.158 |
| Net Debt Paydown Yield | 0.08% |